ATE441859T1 - Verfahren zur diagnose der immunität wiederkehrenden spontanen schwangerschaftsabbruchs sowie verfahren zur behandlung und überwachung - Google Patents

Verfahren zur diagnose der immunität wiederkehrenden spontanen schwangerschaftsabbruchs sowie verfahren zur behandlung und überwachung

Info

Publication number
ATE441859T1
ATE441859T1 AT04712989T AT04712989T ATE441859T1 AT E441859 T1 ATE441859 T1 AT E441859T1 AT 04712989 T AT04712989 T AT 04712989T AT 04712989 T AT04712989 T AT 04712989T AT E441859 T1 ATE441859 T1 AT E441859T1
Authority
AT
Austria
Prior art keywords
recurrent spontaneous
monitoring
level
treatment
present
Prior art date
Application number
AT04712989T
Other languages
English (en)
Inventor
Fenglin Chen
Original Assignee
Beijing Xinjing Antai Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Xinjing Antai Medical filed Critical Beijing Xinjing Antai Medical
Application granted granted Critical
Publication of ATE441859T1 publication Critical patent/ATE441859T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrotherapy Devices (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)
  • Peptides Or Proteins (AREA)
AT04712989T 2004-02-20 2004-02-20 Verfahren zur diagnose der immunität wiederkehrenden spontanen schwangerschaftsabbruchs sowie verfahren zur behandlung und überwachung ATE441859T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2004/000134 WO2005080980A1 (fr) 2004-02-20 2004-02-20 Procede pour diagnostiquer un avortement spontane recurrent immunitaire et procede de traitement et de suivi

Publications (1)

Publication Number Publication Date
ATE441859T1 true ATE441859T1 (de) 2009-09-15

Family

ID=34876877

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04712989T ATE441859T1 (de) 2004-02-20 2004-02-20 Verfahren zur diagnose der immunität wiederkehrenden spontanen schwangerschaftsabbruchs sowie verfahren zur behandlung und überwachung

Country Status (6)

Country Link
US (1) US7674590B2 (de)
EP (1) EP1722225B1 (de)
CN (1) CN100504388C (de)
AT (1) ATE441859T1 (de)
DE (1) DE602004022995D1 (de)
WO (1) WO2005080980A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101407843B (zh) * 2008-11-19 2011-03-09 南方医科大学 一种检测导致自然流产的染色体数目异常的试剂盒
WO2011112993A2 (en) * 2010-03-11 2011-09-15 University Of Louisville Research Foundation, Inc. Methods of predicting and decreasing the risk of pregnancy loss
CN111254111A (zh) * 2020-02-29 2020-06-09 贵州医科大学 靶向治疗习惯性流产和免疫性不孕的细胞及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2836362A1 (de) 1978-08-19 1980-03-06 Behringwerke Ag Diagnostisches mittel
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
WO1983000877A1 (en) * 1981-08-31 1983-03-17 Icl Scient Glucose oxidase immunohistochemical detection of antinuclear antibodies
US5281522A (en) * 1988-09-15 1994-01-25 Adeza Biomedical Corporation Reagents and kits for determination of fetal fibronectin in a vaginal sample
WO1993009432A1 (en) * 1991-11-04 1993-05-13 Adeza Biomedical Corporation Screening method for identifying women at increased risk for imminent delivery
CN1102097A (zh) * 1993-10-29 1995-05-03 泰安市中医医院 人早期胚胎因子及其制取法和在制药中的应用
JPH09218202A (ja) 1995-12-08 1997-08-19 B M L:Kk 抗核抗体の検出方法及び検出用キット
WO2002042769A1 (en) 2000-11-22 2002-05-30 Matsuura, Eiji Method of assaying antilaminin-1 antibody and application thereof
CN1171612C (zh) * 2002-04-02 2004-10-20 复旦大学附属妇产科医院 一种治疗自然流产的中药复方制剂及其制备方法
EP1719516B1 (de) * 2004-02-20 2009-09-02 Beijing Xinjing Antai Medical And Technology Service Limited Corp. Pharmazeutische zusammensetzung zur behandlung von wiederholt auftretendem spontanabort und verfahren dafür

Also Published As

Publication number Publication date
EP1722225B1 (de) 2009-09-02
WO2005080980A1 (fr) 2005-09-01
CN100504388C (zh) 2009-06-24
EP1722225A1 (de) 2006-11-15
DE602004022995D1 (de) 2009-10-15
EP1722225A4 (de) 2007-07-11
US7674590B2 (en) 2010-03-09
US20070160997A1 (en) 2007-07-12
CN1867829A (zh) 2006-11-22

Similar Documents

Publication Publication Date Title
AU2003213594A1 (en) Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples
ATE533061T1 (de) Verfahren zur diagnose bakterieller infektionen
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
WO2005029091A3 (en) Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases
DE602004024539D1 (de) Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben
ATE386942T1 (de) Verfahren zur voraussage, zur diagnose und zur vergleichenden diagnose von alzheimer
DE60300339D1 (de) Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben
DK1421215T3 (da) Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA
ATE223051T1 (de) Verfahren zur diagnose gutartiger prostataerkrankungen
DE602006014535D1 (de) Verwendung von nt-proanp und nt-probnp zur diagnose von herzerkrankungen
DE60126592D1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
WO2004058044A3 (en) Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
DE602004022150D1 (de) Verfahren und kit zum nachweis des frühstadiums einer nierentubuluszellenverletzung
NO20050186L (no) Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser
SG171691A1 (en) Biomarkers for diagnosing multiple sclerosis, and methods thereof
EP1977234A4 (de) Moleküle zur behandlung von lungenerkrankungen mit einer immunreaktion mit verbindungsgewebe in der lunge
AU2003259222A1 (en) Method of diagnosing alzheimer's disease
WO2005098433A3 (en) Diagnostic assays for alzheimer’s disease
DE602004022995D1 (de) Verfahren zur diagnose der immunität wiederkehrendren zur behandlung und überwachung
ATE465408T1 (de) Verfahren zur diagnose und überwachung von neurologischen erkrankungen durch nachweis eines encephalotoxins
DE50313393D1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
WO2007015113A3 (en) New protein isoforms of the pif-family and uses thereof
ATE354095T1 (de) Verfahren zur detektion von prp unter verwendung ein makrozyklischen ligand
BRPI0408067A (pt) disgnóstico de autismo
WO2006067792A3 (en) Aldolase autoantigens useful in diagnosis and treatment of alzheimer's disease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties